Class Action
Jun. 6, 2023
1st class action against pharma company certified under civil RICO
“The result should come as no surprise. It is rooted in well-established 9th Circuit precedent and, frankly, common sense,” Managing Partner R. Brent Wisner said in a statement.
A federal judge in California on Monday unsealed an order certifying a class action alleging that two pharmaceutical companies falsified and concealed data that their diabetes drug, Actos, increased a patient’s risk of developing bladder cancer.
It’s the first class action against a pharmaceutical company certified under the civil RICO statute, which can award treble damages, with this case potentially reaching $7 billion or more, accordin...
For only $95 a month (the price of 2 article purchases)
Receive unlimited article access and full access to our archives,
Daily Appellate Report, award winning columns, and our
Verdicts and Settlements.
Or
$795 for an entire year!
Or access this article for $45
(Purchase provides 7-day access to this article. Printing, posting or downloading is not allowed.)
Already a subscriber?
Sign In